As of May 31
| -1.62 / -2.61%|
The 1 analysts offering 12-month price forecasts for USANA Health Sciences Inc have a median target of 56.00, with a high estimate of 56.00 and a low estimate of 56.00. The median estimate represents a -7.80% decrease from the last price of 60.74.
The current consensus among 1 polled investment analysts is to Hold stock in USANA Health Sciences Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.